Q2 results show wider loss and sharply lower revenue
DataMeds AI posted a net loss of USD 18.36 million for the quarter ended June 30, 2026, widening from a year earlier.
Net revenues fell 77.2% to USD 1.78 million from the prior-year quarter, with distribution revenue down to USD 66,765.
Pharmacy retail sales climbed to USD 1.59 million, partly offsetting the distribution slump tied to liquidity constraints that limited product procurement.
Operating loss widened to USD 7.35 million, while total other expense increased to USD 11.02 million on an USD 8.38 million debt extinguishment loss.
Cash and cash equivalents totaled USD 2.46 million at June 30, 2026, with a working capital deficit of USD 33.78 million.
MEDS•
